| |
| |
|
| Insider
Information: |
Finn John |
| Relationship: |
Chief Scientific Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
Chief Scientific Officer |
2013-09-11 |
0 |
2013-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(166,860) |
0 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,230) |
0 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-07-22 |
4 |
AS |
$12.10 |
$12,100 |
I/I |
(1,000) |
166,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-07-15 |
4 |
AS |
$10.55 |
$36,925 |
I/I |
(3,500) |
167,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-07-12 |
4 |
AS |
$10.10 |
$50,500 |
I/I |
(5,000) |
171,360 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-07-11 |
4 |
AS |
$9.32 |
$4,660 |
I/I |
(500) |
176,360 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-07-10 |
4 |
AS |
$8.58 |
$8,580 |
I/I |
(1,000) |
176,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-06-12 |
4 |
AS |
$9.08 |
$27,250 |
I/I |
(3,000) |
177,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-06-11 |
4 |
AS |
$8.94 |
$8,940 |
I/I |
(1,000) |
180,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-05-14 |
4 |
AS |
$8.10 |
$40,512 |
D/D |
(5,000) |
181,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-05-10 |
4 |
AS |
$7.48 |
$22,425 |
D/D |
(3,000) |
186,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-05-10 |
4/A |
AS |
$7.48 |
$22,425 |
I/I |
(3,000) |
186,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-04-24 |
4 |
AS |
$7.10 |
$3,550 |
I/I |
(500) |
189,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2013-03-15 |
4 |
AS |
$7.10 |
$10,650 |
I/I |
(1,500) |
190,360 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2012-03-26 |
4 |
OE |
$0.52 |
$10,400 |
I/I |
20,000 |
191,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-09-15 |
4 |
AS |
$6.47 |
$6,470 |
I/I |
(1,000) |
172,360 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-08-12 |
4 |
AS |
$7.00 |
$2,100 |
I/I |
(300) |
173,360 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-08-11 |
4 |
AS |
$7.00 |
$1,400 |
I/I |
(200) |
173,660 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-08-09 |
4 |
AS |
$5.82 |
$5,964 |
I/I |
(1,000) |
173,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-07-20 |
4 |
AS |
$8.00 |
$4,000 |
I/I |
(500) |
174,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-07-12 |
4 |
AS |
$7.23 |
$10,846 |
I/I |
(1,500) |
175,360 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-06-09 |
4 |
AS |
$8.09 |
$16,188 |
I/I |
(2,000) |
176,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-05-16 |
4 |
AS |
$8.02 |
$56,163 |
I/I |
(7,000) |
178,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-05-12 |
4 |
AS |
$7.00 |
$10,500 |
I/I |
(1,500) |
185,860 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Chief Scientific Officer |
• – – |
2011-05-10 |
4 |
AS |
$6.02 |
$6,018 |
I/I |
(1,000) |
187,360 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
